rebuild: effect of daratumumab on bone metabolism in r/r myeloma
Published 3 years ago • 88 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:16
mechanism of action & use of daratumumab in multiple myeloma
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
1:12
altered metabolism in multiple myeloma
-
6:59
nanotechnology for bone regeneration
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
16:06
griffin study: daratumumab, lenalidomide, bortezomib, and dexamethasone for multiple myeloma
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
2:46
the impact of daratumumab on the myeloma treatment landscape
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
1:10
latest developments in the treatment of emd in myeloma
-
3:55
cassiopeia: analysis of daratumumab maintenance for myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:41
mechanism of action of the tri-specific t-cell activating construct hpn217 in r/r multiple myeloma
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma